The Chemours Aktie
WKN DE: A14RPH / ISIN: US1638511089
04.11.2024 13:52:56
|
Chemours Reports Loss In Q3, But Sales Rise
(RTTNews) - The Chemours Company (CC), a provider of industrial and specialty chemicals products, Monday reported net loss of $27 million or $0.18 per share for the third quarter, compared with net profit of $12 million, or $0.08 per share in the same quarter a year ago, primarily impacted by a non-cash impairment charge of $56 million.
Excluding one-time items, earnings rose to $61 million or $0.40 per share from $65 million or $0.43 per share last year.
Sales for the quarter were $1.501 billion, up from $1.487 billion in the previous year.
On average, 9 analysts expected the company to report earnings of $0.28 per share on sales of $1.44 billion for the quarter. Analysts' estimates typically exclude special items.
For the fourth quarter, the company anticipates sales to decrease in the mid to high-single digits sequentially.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu The Chemours Co When Issuedmehr Nachrichten
05.05.25 |
Ausblick: The Chemours stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
21.04.25 |
Erste Schätzungen: The Chemours legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
17.02.25 |
Ausblick: The Chemours stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) |
Analysen zu The Chemours Co When Issuedmehr Analysen
Aktien in diesem Artikel
The Chemours Co When Issued | 11,62 | -1,48% |
|